Champions Oncology, Inc.
CSBR
$7.05
-$0.02-0.28%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.32% | -133.21% | -1,583.49% | 277.67% | 135.15% |
| Total Depreciation and Amortization | -10.53% | -20.27% | -13.79% | -17.26% | -17.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 587.23% | 0.63% | -45.25% | -31.92% | -77.73% |
| Change in Net Operating Assets | -99.80% | 110.33% | 339.45% | -1,411.20% | -185.75% |
| Cash from Operations | -513.07% | 92.93% | 478.19% | 153.32% | -148.05% |
| Capital Expenditure | -157.45% | -- | -8,533.33% | 54.35% | -18.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -157.45% | -- | -8,533.33% | 54.35% | -18.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.41% | -2.70% | 0.00% | -11.76% | 50.00% |
| Issuance of Common Stock | -25.00% | -- | 500.00% | -- | 15.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -29.71% | 62.16% | 13.51% | 100.00% | 78.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,210.87% | 97.08% | 455.84% | 142.87% | -121.43% |